Type: News
Date: 04/22/2021

Taft Serves as Legal Counsel to StemoniX in Merger with Cancer Genetics

Taft is pleased to have acted as legal counsel to StemoniX, Inc. a company empowering the discovery of new medicines through the convergence of novel human biology and software technologies in its merger with Cancer Genetics, Inc., an emerging leader in novel drug discovery techniques. In connection with the merger, Cancer Genetics was renamed Vyant Bio and StemoniX will operate as a wholly-owned subsidiary of the company. Read the full release here.

Taft’s legal team included, among others, Steve Kozachok, Kathleen Eick, Jim Duffy, Blake Vettel, Leanna Longley, Lourdes Perrino, and Jeff Siwik.

In This Article

You May Also Like